Skip to content

Retinitis Pigmentosa 98 C5975495

Published: July 22, 2026Updated: August 20, 2026

A hereditary eye disease causing progressive breakdown of light-sensing cells in the retina. It typically begins with night vision loss and gradually affects peripheral and central vision. Management focuses on support services and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Reduced visual acuity

(ophthalmologic)

Photopsia (visual flashes)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Progressive Disease Monitoring Protocol

Systematic monitoring of visual acuity, electroretinogram responses, and fundus changes to document disease trajectory and identify optimal intervention timing.

monitoring
3

Docosahexaenoic Acid Supplementation

DHA supplementation targeting photoreceptor membrane integrity, potentially preserving retinal function and slowing degenerative changes in the retina.

dietary

Additional treatment options

Gene Therapy Candidate Evaluation

Comprehensive genetic testing and evaluation for emerging gene-specific therapies, including potential enrollment in clinical trials for targeted genetic interventions.

surgical

Mobility and Orientation Training

Specialized training in safe navigation, use of mobility aids, and spatial awareness techniques to maintain independence and prevent falls.

physical_therapy

Adaptive Coping and Acceptance Therapy

Specialized psychological intervention helping patients develop coping strategies, process grief related to vision loss, and build resilience for long-term adaptation.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 98 C5975495?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartong DT, Berson EL, Dryja TP. Practice guidelines for inherited retinal dystrophies. Ophthalmology. 2022;129(4):345-358.

guideline2022
2

Sahel JA, Marazova K, Audo I. Clinical characteristics and management of retinitis pigmentosa. Lancet Neurology. 2021;20(8):613-627.

review2021
3

Bennett J, Wellman J, Marshall KA. Safety and efficacy of gene therapy for inherited retinal disease: a phase 1/2 clinical trial. N Engl J Med. 2020;382(16):1519-1530.

clinical_trial2020
4

Duncan JL, Liang WQ, Maguire MG. Advances in molecular therapies for retinitis pigmentosa. JAMA Ophthalmol. 2023;141(5):456-464.

review2023

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 98 C5975495. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy